These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6403228)

  • 1. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice.
    Argyris TS
    Cancer Res; 1983 Apr; 43(4):1768-73. PubMed ID: 6403228
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5'-monophosphate, and induction of mouse skin tumors in vivo.
    Mufson RA; Fischer SM; Verma AK; Gleason GL; Slaga TJ; Boutwell RK
    Cancer Res; 1979 Dec; 39(12):4791-5. PubMed ID: 227591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
    Slaga TJ; Fischer SM; Nelson K; Gleason GL
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal cell proliferation and promoting ability of phorbol esters.
    Slaga TJ; Scribner JD; Viaje A
    J Natl Cancer Inst; 1976 Nov; 57(5):1145-9. PubMed ID: 826651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion.
    Ordman AB; Cleaveland JS; Boutwell RK
    Cancer Lett; 1985 Oct; 29(1):79-84. PubMed ID: 3933814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of octahydromezerein and mezerein as protein kinase C activators and as mouse skin tumor promoters.
    Sharkey NA; Hennings H; Yuspa SH; Blumberg PM
    Carcinogenesis; 1989 Oct; 10(10):1937-41. PubMed ID: 2507191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of tumour promotion in chemical carcinogenesis.
    Boutwell RK
    IARC Sci Publ; 1984; (56):3-11. PubMed ID: 6443106
    [No Abstract]   [Full Text] [Related]  

  • 8. Stages of tumour promotion in skin.
    Marks F; Fürstenberger G
    IARC Sci Publ; 1984; (56):13-22. PubMed ID: 6443102
    [No Abstract]   [Full Text] [Related]  

  • 9. Regeneration and the mechanism of epidermal tumor promotion.
    Argyris TS
    Crit Rev Toxicol; 1985; 14(3):211-58. PubMed ID: 3893895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced trisialoganglioside synthesis in chemically but not mos-transformed mouse epidermal cells.
    Srinivas L; Colburn NH
    Cancer Res; 1984 Apr; 44(4):1510-4. PubMed ID: 6608408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between sensitivity to tumor promotion and sustained epidermal hyperplasia of mice and rats treated with 12-O-tetra-decanoylphorbol-13-acetate.
    Sisskin EE; Gray T; Barrett JC
    Carcinogenesis; 1982; 3(4):403-7. PubMed ID: 6807562
    [No Abstract]   [Full Text] [Related]  

  • 12. The chlorinated pesticide mirex is a novel nonphorbol ester-type tumor promoter in mouse skin.
    Moser GJ; Meyer SA; Smart RC
    Cancer Res; 1992 Feb; 52(3):631-6. PubMed ID: 1732051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis.
    Park KK; Chun KS; Yook JI; Surh YJ
    Anticancer Res; 1998; 18(6A):4201-5. PubMed ID: 9891468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic component of phorbol ester-induced mouse skin inflammation.
    Szallasi A; Blumberg PM
    Cancer Res; 1989 Nov; 49(21):6052-7. PubMed ID: 2790819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin tumor promotion by phorbol esters is a two-stage process.
    Fürstenberger G; Berry DL; Sorg B; Marks F
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7722-6. PubMed ID: 6801661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
    Slaga TJ; Fischer SM; Weeks CE; Nelson K; Mamrack M; Klein-Szanto AJ
    Carcinog Compr Surv; 1982; 7():19-34. PubMed ID: 7039828
    [No Abstract]   [Full Text] [Related]  

  • 17. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
    Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TPA dose variation and mezerein on skin tumorigenesis by initiation promotion protocol in S/RV Cri mice.
    Bhisey RA; Veturkar PL; Jeyapaul J; Borges A
    Indian J Exp Biol; 1988 Oct; 26(10):764-7. PubMed ID: 3248829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.